Bioqual (Bioqual) Change In Receivables : $-1.34 Mil (TTM As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual Change In Receivables?

Bioqual's change in receivables for the quarter that ended in May. 2018 was $-1.34 Mil. It means Bioqual's Accounts Receivable increased by $1.34 Mil from May. 2017 to May. 2018 .

Bioqual's change in receivables for the fiscal year that ended in May. 2018 was $-1.34 Mil. It means Bioqual's Accounts Receivable increased by $1.34 Mil from May. 2017 to May. 2018 .

Bioqual's Accounts Receivable for the quarter that ended in May. 2018 was $9.27 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bioqual's Days Sales Outstanding for the six months ended in May. 2018 was 47.12.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bioqual's liquidation value for the six months ended in May. 2018 was $12.85 Mil.

Bioqual Change In Receivables Historical Data

The historical data trend for Bioqual's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Change In Receivables Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

Change In Receivables

Get a 7-Day Free Trial

-0.44

-0.48

-1.89

0.97

-1.34

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
Change In Receivables	Get a 7-Day Free Trial										-0.44	-0.48	-1.89	0.97	-1.34

Bioqual Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in May. 2018 was $-1.34 Mil.

Bioqual (OTCPK:BIOQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bioqual's Days Sales Outstanding for the quarter that ended in May. 2018 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	9.265	/	35.885	*	91
=	47.12

2. In Ben Graham's calculation of liquidation value, Bioqual's accounts receivable are only considered to be worth 75% of book value:

Bioqual's liquidation value for the quarter that ended in May. 2018 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	10.161	-	4.255	+	0.75 * 9.265	+	0.5 * 0
=	12.85

Bioqual Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bioqual's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Change In Receivables

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines